Eli Lilly and Company Planning New Irish Biopharma Plant

Published: Dec 15, 2011

Eli Lilly has filed a planning application to build a new 23,000 sq. m. biologics facility at its manufacturing site in County Cork, Ireland. The three-story building marks another phase of investment in the biopharmaceutical-producing capacity of the site in Dunderrow, Kinsale, coming after a €400 million project to build a 158,000 sq. m. facility there started in 2008. Construction of the biomanufacturing plant - which specialises in monoclonal antibodies - was completed in 2010 and it is due to come fully online next year.

Back to news